Compare ELTX & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELTX | MNTK |
|---|---|---|
| Founded | 2011 | 1980 |
| Country | United States | United States |
| Employees | 33 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.4M | 202.0M |
| IPO Year | 2014 | 2020 |
| Metric | ELTX | MNTK |
|---|---|---|
| Price | $9.91 | $1.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $18.00 | $1.80 |
| AVG Volume (30 Days) | 112.2K | ★ 267.0K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.29 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,301,000.00 | ★ $176,382,000.00 |
| Revenue This Year | N/A | $18.55 |
| Revenue Next Year | N/A | $12.68 |
| P/E Ratio | ★ N/A | $146.00 |
| Revenue Growth | N/A | ★ 0.37 |
| 52 Week Low | $5.80 | $1.07 |
| 52 Week High | $14.93 | $2.78 |
| Indicator | ELTX | MNTK |
|---|---|---|
| Relative Strength Index (RSI) | 38.27 | 47.64 |
| Support Level | $8.76 | $1.08 |
| Resistance Level | $10.16 | $1.58 |
| Average True Range (ATR) | 0.75 | 0.11 |
| MACD | -0.19 | 0.00 |
| Stochastic Oscillator | 2.14 | 11.11 |
Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.